Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection

Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection

<p>The rate at which HIV-1 infected individuals progress to AIDS is highly variable and impacted by T cell immunity. CD8 T cell inhibitory molecules are up-regulated in HIV-1 infection and associate with immune dysfunction. We evaluated participants (n=122) recruited to the SPARTAC randomised...

Full description

Bibliographic Details
Main Authors:	Hoffmann, M, Pantazis, N, Martin, G, Hickling, S, Hurst, J, Meyerowitz, J, Willberg, C, Robinson, N, Brown, H, Fisher, M, Kinloch, S, Babiker, A, Weber, J, Nwokolo, N, Fox, J, Fidler, S, Phillips, R, Frater, A
Format:	Journal article
Published:	Public Library of Science 2016

Similar Items

HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial
by: Frater, A, et al.
Published: (2013)

HIV-1 DNA predicts disease progression and post-treatment virological control.
by: Williams, J, et al.
Published: (2014)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
by: Hurst, J, et al.
Published: (2015)

Enrichment of the HIV reservoir in CD32+CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
by: Martin, GE, et al.
Published: (2017)

Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection
by: Frater, J, et al.
Published: (2019)

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.
by: Fidler, S, et al.
Published: (2007)

Protective HLA class I alleles are associated with reduced immune activation and fibrinolysis in individuals with primary HIV infection
by: Hamlyn, E, et al.
Published: (2010)

CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNA
by: Martin, G, et al.
Published: (2018)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008)

Structured observations reveal slow HIV-1 CTL escape
by: Roberts, H, et al.
Published: (2015)

Levels of human immunodeficiency virus DNA are determined before art initiation and linked to CD8 T-cell activation and memory expansion
by: Martin, GE, et al.
Published: (2019)

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.
by: Hamlyn, E, et al.
Published: (2012)

The impact of vorinostat and therapeutic vaccine on gut HIV DNA: the RIVER gut study
by: Thornhill, J, et al.
Published: (2019)

HIV-1 drug resistance in primary infections in the UK.
by: Fidler, S, et al.
Published: (2001)

Longitudinal analysis of an HLA-B*51-restricted epitope in integrase reveals immune escape in early HIV-1 infection.
by: Yager, N, et al.
Published: (2013)

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
by: Tiraboschi, J, et al.
Published: (2017)

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial
by: Tiraboschi, J, et al.
Published: (2017)

Short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2013)

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype
by: Thornhill, J, et al.
Published: (2019)

Immunotherapeutic approaches to HIV cure and remission
by: Lee, MJ, et al.
Published: (2021)

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
by: Day, C, et al.
Published: (2006)

Advancing the HIV cure agenda: the next 5 years.
by: Thornhill, J, et al.
Published: (2015)

Maintenance of Functional CD57+Cytolytic CD4+T Cells in HIV plus Elite Controllers
by: Phetsouphanh, C, et al.
Published: (2019)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Early antiretroviral therapy reduces hiv dna following perinatal HIV infection
by: Foster, C, et al.
Published: (2017)

Histone deacetylase inhibitors enhance CD4 T cell susceptibility to NK cell killing but reduce NK cell function
by: Pace, M, et al.
Published: (2016)

HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.
by: Duda, A, et al.
Published: (2009)

The role of the gut mucosa in protection from HIV-1 in highly exposed persistently seronegative individuals (HEPS)
by: Fox, J, et al.
Published: (2009)

A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study
by: Fidler, S, et al.
Published: (2017)

The Role of CD4+ T Follicular Helper Cells in HIV Infection: From the Germinal Center to the Periphery.
by: Thornhill, J, et al.
Published: (2017)

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
by: Scriba, T, et al.
Published: (2005)

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.
by: Scriba, T, et al.
Published: (2005)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
by: Stöhr, W, et al.
Published: (2013)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection
by: Martin, G, et al.
Published: (2017)

Human immunodeficiency virus infection impairs Th1 and Th17 Mycobacterium tuberculosis–specific T-cell responses
by: Murray, L, et al.
Published: (2018)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
by: Fidler, S, et al.
Published: (2017)

A randomised controlled trial comparing the impact of Antiretroviral Therapy (ART) with a ‘Kick-and-Kill’ approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial
by: Fidler, S, et al.
Published: (2018)

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
by: Hamlyn, E, et al.
Published: (2012)